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Lymphocytes: 1979t 
Sudhir Gupta, MD* and Robert A. Good, PhD, MD** 
Rapid progress has been made in understanding the com-
plexity of the immune system. The current status of lympho-
cyte subpopulations with regard to ontogenic development, 
their surface and intracellular markers, and functions in 
various Immunologic phenomena has been reviewed. Het-
erogeneity of T lymphocytes as defined by receptors for 
immunoglobulin isotypes is discussed in detail. Various cell 
types and their products involved in immunoregulatlon are 
also presented. 
Lymphocytes play a critical role in immune responses. 
During the last twenty years rapid progress has been made 
in immunobiology to clarify the role of lymphocytes in 
immunological phenomena in animals and man. Studies in 
experimental animals and in experiments of nature in 
humans led tothe discovery of two major lymphoid compo-
nents of specific immunity (Fig. 1). Both lines of lymphoid 
cells derive from a common, primitive precursor stem cell. 
Committed lymphoid stem cells follow different routes of 
differentiation and maturation intoT and B lymphocytes. By 
one route, they enter the thymus and under its inductive 
influences begin a sequence of differentiation stages to 
mature into immunoregulatory and effector T cells that 
perform functions of cell-mediated immunity. By an alter-
nate route, stem cells are processed in fetal liver and later in 
bone marrow. These differentiate and mature into B cells, 
which on terminal differentiation become plasma cells 
highly specialized to synthesize and secrete specific anti-
body. These cells thus subserve the function of humoral or 
antibody-mediated immunity. During differentiation and 
maturation, lymphocytes develop surface receptors and 
differentiation antigens and many distinct functions. The 
studies of cell surface receptors and the development of 
methods for identifying and separating the several sub-
populations have contributed greatly to understanding the 
lymphoid system and its functions as effector cells and as 
regulators and monitors ofthe immunologic adaptations. 
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Fig.1 
Ontogeny of T cell lineage 
The thymus originates at about six weeks of gestation from 
the junction ofthe ectodermal and endodermal epithelium 
ofthe third and fourth pharyngeal pouches as a single layer 
of epithelial cells. In man, lymphocytes are demonstrable 
within this organ by the eighth and ninth week of gestation. 
The epithelial anlagen of the thymus appears at about the 
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10th embryonal day and has been invaded by mesenchyo-
mal cells by the 11th or 12th day. An imal studies indicate that 
precursors of lymphoid cells appear in the fetal liver and 
migrate to the thymic epithelium (1). In man at the n-19th 
week of gestational age, thymus contains up to 659^ cells 
that form rosettes with sheep RBC (SRBC) (2).* Stites and 
associates (3) reported that almost all fetal thymocytes 
between 12-20 weeks of gestation react specifically with 
antifetal thymocyte serum, as demonstrated by indirect 
immunofluorescence technique. Antigen-binding cells are 
maximal in fetal thymus and represent a smaller population 
in the thymuses of children and young adults (4). 
The proliferative response of fetal thymocytes to PHA (5) 
begins as early as the Mth week of gestation and increases 
until the 18th week, after which responses decline to adult 
levels (6). The appearance of proliferative responses of 
thymocytes to PHA correlates with the demarcation of 
thymus into cortex and medulla (7). Further morphological 
study suggests that thymic medulla contains these PHA-
responsive thymocytes (6). PHA-responsive lymphocytes 
appear in the spleen two weeks after such cells appear in 
the thymus (8), but bone marrow and fetal liver cells fail to 
respond to PHA at this time (9). 
The ontogeny of responding cells in one-way, mixed leuko-
cyte culture reaction (MLR) has been studied by a numberof 
investigators. Stites, et al (9) have reported the presence of 
MLR-responsive cells in fetal liver as early as 7.5 weeks of 
gestational age. Carr and associates (10) demonstrated no 
clear correlation between a strong response of lymphoid 
cells from fetal liver to allogeneic cells and failure to 
respond to PHA. MLR-responsive cells were also present in 
fetal spleen and thymus. These observations suggest that 
capacity for MLR may be distinct and more primitive than 
reactivity to PHA. PHA-induced, cell-mediated cytotoxicity 
is lacking from fetal thymuses (14-18 weeks gestational age) 
at a time when fetal bone marrow cells respond to PHA by 
developing cytotoxic potential against target chicken RBC. 
By contrast, at the same developmental stage these cells 
failed to proliferate in response to PHA (11). Peripheral 
blood and splenic lymphocytes from the same fetuses 
proliferated and became cytotoxic in response to PHA, 
while liver lymphoid cells failed to respond in either test. 
DIFFERENTIATION RECEPTORS ON HLIIAN T LYMPHOCYTES 
PHA+ CON A+ 
S Lem 
CeU 
The fetal lymphoid cells capable of producing graft versus 
host reaction (GVHR) are present in splenocytes from 13-23 
week-old fetuses. No definitive information is available asto 
the earliest appearance of cells capable of influencing 
GVHR (12). 
Touraine, et al (13,14) studied in vitro and in vivo expression 
of differentiation markers on cells of T cell lineage by 
incubating the bone marrow cells with thymic factors In 
vitro and by sequential study of patients with DiGeorge 
syndrome who had received thymic transplants. The 
scheme derived from these studies indicates a sequential 
and bifurcated development of T cells (Fig. 2). Hirano, etal 
(14a) have brought forward evidence to support this inter-
pretation which uses definition of T lymphocyte subpopula-
tions by antisera against T cell lines. 
Receptors for peanut agglutinin and high terminal deox-
ynucleotidyl transferase (TdT) activity appear to be very 
early markers for identifying cells in the T cell lineage. 
However, these two receptors do not appear to be confined 
exclusively to cells of T cell lineage. The binding sites of 
peanut agglutinin, for example, are present on cells from 
Burkitt lymphoma (B cell lineage) and from acute myeloid 
leukemia (15). Similarly, high TdT activity has been reported 
in the malignant cells of patients with pre-B cell leukemia 
(16). Therefore, it is evident that these two markers are 
features of relatively immature cells of both lymphoid and 
nonlymphoid lineage. Among cells of the T cell lineage, 
they are present on pre-T or relatively immature T cells but 
are lacking from mature Tcells. Our studies of Tcell subsets 
obtained from various lymphoid organs, as identified by 
receptors for Ig, demonstrated that SRBC rosette-forming 
' Abbreviations used in this paper: 
ADCC — antibody-dependent cellular cytotoxicity 
Con A — Concanavalin A 
EBV—Epstein-Barr virus 
EREC — sheep RBC rosette forming cells 
GVHR — graft-versus-host reaction 
HTLA— human T lymphocyte antigen 
MIF — migration inhibition factor 
MLR — mixed leukocyte culture reaction 
MHC — major histocompatibility complex 
MRBC — mouse red blood cells 
nk — natural killer 
PNA— peanut agglutinin 
PHA — phytohemagglutinin 
PWM — pokeweed mitogen 
SRBC — sheep red blood cells 
TdT — terminal deoxynucleotidyl transferase 
T/J. — T cells with receptors for IgM 
Ty — T cells with receptors for IgG 
Ta — T cells with receptors for IgA 
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T Cell-Dependent 
thymocytes lack receptors for IgM (J/JL), IgG (Ty), or IgA (Ta) 
receptors. These findings suggest that lg receptors on T cells 
develop after receptors for SRBC have appeared (17-19). 
Ontogeny of B cell lineage 
The ontogeny of mammalian B cells has been most exten-
sively studied in mice. Theearliest identifiable cell isa large 
cell with intracytoplasmic IgM but without surface IgM that 
appears in the liver of 12-13 day-old mouse fetus (20-22). B 
cells with surface IgM first appear in the fetal liver around 
16-17 days of gestation; they have now also been found in 
rabbits and human fetal liver and in the bursa of Fabricius of 
the chick embryo (23,24). In man, pre-B cells were present 
in the fetal liverof a 5-7 week fetus which lacked any surface 
IgM -F B lymphocytes (24). 
According to morphologic and kinetic studies, pre-B cells 
appear divisible into two classes. Large pre-B cells (17 /a) 
haveadeeply indentedorconvoluted nucleusand represent 
a rapidly dividing cell population. Small pre-B cells (8 /x)are 
morphologically similar to surface IgM + B cells but lack 
surface IgM and divide slowly. In the human, mouse, and 
rabbit, pre-B cells are found predominantly in the fetal liver 
and bone marrow but may be present in lower frequencies 
in fetal spleen and lymph nodes. The study of pre-B cell 
leukemias (16) demonstrated that la antigen was present on 
pre-B cells. Up to the 13th week of gestation, they outnum-
ber surface IgM -E B cells in fetal liver. B lymphocytes 
bearing only surface IgM develop earlier than do cells 
bearing other lg classes (25,26), e.g., those that express 
surface IgD, IgG or IgA. Initially, IgD appears exclusively on 
immature B cells which also bear surface IgM. The ratio of 
lymphocytes with surface IgM alone to those bearing both 
IgM and IgD probably serves as a good index of maturity ofa 
B cell population. The position in the sequence of ap-
pearance of lymphocytes with surface IgE in human fetuses 
has not yet been elucidated (Fig. 3). However, a study of 
hooded Lister strain rats (27) demonstrates that surface, IgE-
bearing B lymphocytes are derived from B cellswith surface 
IgM. Observations in rat, mouse, and now in human, concur 
with the viewthat precursors foreach immunoglobulin class 
of B cells are derived directly from separate surface IgM-
bearingcell lines (Fig. 3). While Fc receptor-positive lym-
phoid cells are found in human fetal liver as frequently as 
surface IgM -I- B cells (26), large pre-B cells do not bear Fc 
receptors. Complement receptor (C3) bearing lymphoid cells 
are present in fetal liver in proportions much smaller than 
those for cells with surface IgM and/or Fc receptors and are 
lacking in the early gestational period when the other two 
receptors are present. The receptor for mouse RBC (MRBC) 
is present as early as surface IgM and perhaps is present on 
pre-B cells. A scheme of sequential development of recep-
tors on cells of B cell lineage is shown in Fig. 4. 
A MODEL FOR B CELL DIFFERENTIATION 
( D — I 
Stem Cell Large Small Immature Virqir 
Pre B Cell Pre B Cell B Cell B Ce 
Virgin Immune Plasma 
B Cells B Cells Cells 
Fig. 3 
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Markers of human lymphoid cells 
During differentiation and maturation, lymphoid cells dis-
play a variety of cell surface markers. Based on surface 
marker analysis, they have been classified into three major 
subpopulations: T, B, and so-called third population or null 
cells (Table 1). 
Lineage of B lymphocytes 
Pre-B lymphocytes of mouse and man are characterized by 
the presence of intracytoplasmic IgM without surface IgM. 
They are present in very small numbers (—1%) in the bone 
marrow of young adults but are absent from the peripheral 
blood. Malignant proliferations ofthe pre-B cell population 
have now been reported (16). Although indirect evidence 
suggests that receptors for MRBC are present on pre-B cells, 
direct evidence is lacking. Receptors for MRBC are also 
present on a subset of mature B cells (28-30). Studies of 
ontogeny as well as of blood from patients with lympho-
proliferative disorders suggest that MRBC receptors appear 
on B cells at an early stage of maturation but not on B cells 
and plasma cells that actively secret lg. 
B lymphocytes are identified by the presence of surface Ig 
that is the product of the cell carrying Ig on its surface. 
Approximately 10^ receptor Ig molecules are present on a 
single B cell and approximately 10-14% of peripheral blood 
lymphocytes express such surface Ig. Surface IgM-bearing 
lymphocytes comprise most of the circulating B lympho-
cytes, whereas only a minor population of B lymphocytes in 
the circulating blood have surface IgG, IgA, or IgE. Among 
IgG subclasses, IgG? appears to be dominant on the surface 
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TABLE I 
Markers of Human Lymphoid Cell Subpopulations 
B Cell Lineage 
Stem Cell ?Alloantigen 
Pre-B Cells IntracytoplasmicIgM 
?MRBC receptors 
"la like" antigen 
B Cells 
T Cell Lineage 
Stem Cell 
Pre-T Cells 
T Cells 
Third Population 
Surface immunoglobin 
MRBC receptors 
Epstein-Barr Virus receptor 
IgG Fc receptors 
IgM Fc receptors 
IgA Fc receptors 
Complement component receptors 
B cell aMoantigens ("la like") 
?Alloantigen 
Terminal deoxynucleotidyl transferase (TdT) 
HTLA 
Peanut agglutinin 
HTLA 
SRBC receptors 
Acid a-naphthyl acetic esterase 
IgG Fc receptors (Ty) 
IgM Fc receptors (Tfj.) 
IgA Fc receptors (Ta) 
T|-|2 antigen 
Histamine receptors 
Unclassified" Lymphoid Cells 
IgG Fc receptors 
Complement component receptors 
Receptors for EBV 
"la like" antigen 
of B lymphocytes (33). A restriction to lg class or IgG 
subclass and to Gm antigens has been demonstrated on 
lymphocyte membrane (33). However, both IgM and IgD 
can be regularly demonstrated on the same cell (34,35). 
Using idiotypic antisera, it has been shown that IgD and IgM 
on the same cell have identical hypervariable regions and 
therefore appear to employ the same gene to code for their 
variable regions ofthe Ig (35). IgD is the most susceptible to 
proteolysis, but its precise role still remains to be defined. 
Bourgois and associates (36) have suggested that it may play 
a regulatory role by eliciting an anti-idiotypic response. 
Immature B cells possess surface IgM only; mature B cells 
possess both IgM and IgD. Following activation by antigen 
or mitogen, IgD is lost. Because immature B cells are very 
susceptible to tolerance induction, we suggest that IgD 
prevents tolerance induction and facilitates the positive 
immunological adaptation. 
Receptors for IgG Fc are present on cells from all hema-
topoietic cell lineages. They are also present on B cells, on 
lymphoid cells of the " th i rd" population, and on a sub-
population o f T cells. Fc receptors on B cells and on third 
population cells can be distinguished from each other (37) 
because the former have a lower affinity for complexed IgG 
than the latter. The concentration of soluble immune com-
plexes required to detect binding to the Fc receptors of third 
population cells is 100 times fewer than that required to 
detect B cell Fc receptors. Third population cells are active 
in antibody-dependent (ADCC) and natural cytotoxicity 
(nk), whereas B cells do not mediate such cytotoxicities (38). 
Fc receptors on B lymphocytes have a close spatial associa-
tion with " la l ike" antigens; however, no such association 
has been reported on the surface of cells of the third 
population. B cell Fc receptors via this association may play 
a significant role in the regulation of immune response. 
In recent years, an interrelationship between components of 
thecomplement system and cells of the immune system has 
been recognized. B lymphocytes express membrane recep-
tors for Cab, Cjd, C4b, C,q, Cg, and C^ inhibitor (39-42). 
Factor B activity is associated with peripheral B cells, cells 
from chronic lymphocytic leukemia (CLL), and Raji cells of 
Burkitt's lymphoma. Factor B is present intracellular^ and 
not on the surface of B cells. Thymocytes and erythrocytes 
lack factor B activity. Since lymphocyte factor B is distinct 
from Cab receptor, serum factor B cannot be regarded as 
fluid phase receptor for Cab. Receptors for C3 are trypsin 
sensitive and are present on most but not all B lymphocytes. 
Approximately 6000 C3 molecules are required for maximal 
binding to a lymphocyte. Cab and Cjd receptors, which 
appear to be serologically distinct from each other, cap 
independently on the lymphocyte surface. The C4b receptor 
is present on all o f the same cell types which have Cad 
receptors, except for a few lymphoblastoid lines with recep-
tors for Cab only (41,42). The biological function ofthe C4b 
and Ca receptors appears similar. Receptors for d q are 
present on both T and B lymphocytes. This receptor is 
sensitive to treatment with trypsin but resists treatment with 
neuraminidase or DNase. Although the biological signifi-
cance of C^q receptors is not known at present, it has been 
proposed that they bind to immune complexes, and this 
binding activates a complement sequence that in turn can 
result in change of cellular activity. C3 receptors appear to 
play a part in induction of thymus-dependent antibody 
production. Complement receptors may participate in the 
initial events taking place on the lymphocyte surface during 
antigenic stimulation that leads to antibody production. 
They may also contribute to the follicular localization of 
antigen (45) and the antibody-dependent mechanism that 
brings antigenic substances to certain areas in lymphoid 
organs, presumably for the induction of immune response 
(46,47). 
Epstein-Barr Virus (EBV) is a lymphotropic virus for man and 
for New World monkeys. Jondal and Klein (48) demon-
strated the presence of EBV receptor on some B eel Is of long-
term, culture-maintained lymphoid cell lines, although it is 
lacking from T cells. Greaves, et al (49) also reported that 
EBC receptors are present on virtually all B cells but not on T 
cells and thymocytes. 
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In addition to the classical, serologically defined antigens of 
the major histocompatibility system (HLA-A, B, C), the HLA-
gene complex also includes determinants which regulate 
the ability of cells to stimulate in MLC. In man, during 
studies of certain alloantiserathat selectively inhibited MLC, 
antibodies were present which exhibited a striking specif-
icity for alloantigens present on B cells but not on T 
lymphocytes (50). These antigens are distinct from HLA 
determinants and are designated as HL-B or " la l ike" 
antigens. At least two genetic loci in MHC appear to be 
responsible for the synthesis ofthese polymorphic allotypic 
antigens. It has now becomeclear that"la l ike" antigensare 
not restricted to B lymphocytes but are also present on 
monocytes, precursors of granulocytes, and even on 
erythrocytes (51,52), sperm cells, Langerhan cells of skin, 
and a subpopulation of T cells (53), as well as the third 
population of lymphoid cells. 
Lineage of T lymphocytes 
It is likely that stem cells that have been committed to 
differentiate along the T cell lineage bear a definitive 
alloantigen, although this antigen remains to be defined. As 
discussed in the section of ontogeny of T cells, pre-T cells, 
relatively immature T cells and thymocytes have receptors 
for peanut agglutinin and possess high activity of TdT. 
Another antigen, the human T lymphocyte antigen (HTLA), 
is present on human thymocytes and also on both relatively 
immature and fully mature T cells (13,54). Receptors for 
SRBC are present on thymocytes and peripheral blood T 
cells and absent from other cells of hematopoietic lineage. 
The formation of rosettes between T lymphocytes and SRBC 
is very susceptible to technical variations which influence 
both the proport ions of rosette-forming cells and the 
strength of SRBC binding to lymphocyte. While the bio-
chemical nature ofthe receptor on T lymphocytes for SRBC 
is poorly understood, it is probably a glycoprotein synthe-
sized within hours after enzymatic removal from the T 
lymphocytes by a process requiring protein synthesis but not 
cell replication. 
Human peripheral blood T cells have receptors for Helix 
Promatia A hemagglutinin (HP), but it is also present on a 
subpopulation of B lymphocytes (55,56). There is evidence 
to suggest that the HP receptor on the B cells is also present 
on relatively immature cells (57). 
Alpha-naphthyl acetate esterase (ANAE) activity has been 
used as an enzymatic marker to identify monocytes, but it 
can also be demonstrated in most T cells (58,59). However, 
the staining pattern is quite distinct from that seen on 
monocytes. Whereas ANAE-stained T cells reveal a discrete 
spotted pattern, monocytes reveal a homogeneous rim 
pattern. Knowles, et al (60) reported comparable propor-
tions of ANAE positive and SRBC binding cells in the 
peripheral blood. However, discrepancies between these 
two markers were observed in thymus and spleen, where 
less ANAE activity was recorded in thymocytes than in SRBC 
rosette forming cells. Further, in the spleen ANAE activity 
was demonstrated in non-T cell fractions. 
Human T lymphocytes demonstrate an extraordinary degree 
of heterogeneity, as evidenced by the presence of differ-
entiating antigens (THI and TH2) as well as by receptors for 
immunoglobulins that exist on relatively distinct subsets of 
human T lymphocytes (61-69). THI and TH2 phenotypes 
have been defined either by heterologous anti-Tcell antisera 
which have been absorbed on autologous B cell lines (for 
THI) or by absorption with leukemic cells from a patient 
with T cell type CLL (for TH2). TH1+ cells respond by 
proliferation to mitogens, PHA, Con A, and allogeneic cells 
and produce migration inhibition factor (MIF). TH1+ cells 
do not respond by proliferation to soluble antigen but have 
allogeneic killer activity. TH2+ cells also respond poorly by 
proliferation to soluble antigens. This population appears to 
mediate a powerful killer activity in cell-mediated lympho-
cytes. Hirano, et al (14a) have identified surface antigen on 
human suppressor T cells by using an antiserum against 
human T leukemic cell line HSB absorbed with homologous 
Bcell line. While this antiserum also identifies a population 
of T cells that respond in MLC, it has no effect on helper T 
cells or mitogenic response to PHA and Con A. 
Recently, Strelkauskas, et al (70,71) have demonstrated that 
sera from patients with juvenile rheumatoid arthritis QRA) 
contain antibodies that are directed against a subset of T 
lymphocytes. JRA -E T cells proliferate in response to Con A 
but not to PHA and when isolated from normal individuals 
inhibit immunoglobulin biosynthesis of B cells in plaque 
forming cell (PFC) assay. In contrast, JRA negative T cells 
enhanced immunoglobulin production by B cells. These 
studies clearly demonstrate the presence of antisuppressorT 
cell antibodies in the sera of patients with JRA. It is evident 
that the serum from patients with autoimmune disease may 
provide readily available reagents for further dissection of 
functionally distinct subpopulations of human T cells. 
Human T lymphocytes have also been shown to possess 
receptors for IgM (T/x), IgG (Ty), or IgA (To:) (63-69) which 
can be identified and enumerated by rosette-technique 
using OxRBC-IgM, IgG, or OxRBC-TNP-lgA complexes. 
The receptor for IgM on T/u. cells has specificity for the Fc 
portion ofthe IgM molecule and appears to bind to the Tcell 
receptors by its CH4 domain (72). Both pentameric and 
monomeric IgM could bind to IgM receptors on Jp, cells 
(73). It is likely that IgG receptor on Ty cells binds to 
molecules ofeach class of IgG. Similarly, Ta cells appear to 
bind to both IgAI and lgA2 subclasses of the IgA molecules 
(unpublished observation). T/j. and Ty cells have been 
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extensively studied for the morphological and functional 
characteristics that wi l l be detailed below. 
The 'third' population of lymphoid cells ('null' cells) 
Non-T and non-B cells with lymphoid morphology repre-
sent a somewhat heterogeneous population of cells. Almost 
all have high affinity receptors for IgG Fcand approximately 
two thirds appear to have receptors for EBV and "la like" 
antigens. A very small population also have receptors forCa. 
Recently, it has become clear that under appropriate experi-
mental conditions these cells can differentiate into mature 
erythrocytes, granulocytes, T lymphocytes, or B lympho-
cytes (74-76). They appear to be heterogeneous and are 
comprised of progenitor cells committed for various hema-
topoietic cell lineage; we prefer to call them "unclassified 
cells." 
Functions of lymphocyte subpopulations 
Over the past decade progress has been made in the 
resolution of the multiple genes comprising the major 
histocompatibility complex or super gene of the mouse 
(MHC), called the H-2T1a gene complex. The most signifi-
cant advances in defining the MHC relate to its functional 
role. It has been established that the gene products ofthe K 
and D region are primary targets for the cell-mediated 
cytotoxicity reactions in allograft rejection. Recent studies 
have shown that the most effective cytotoxic reactions 
against virus infected or chemically modified target cells 
require H-2K and / or H-2D identity between the sensitizing 
cells and the target cell. These findings indicate that these 
gene products play a direct role in recognition of the target 
bythe effector cell (77,78). At present, it seems certain that 
this finding reflectsthe fundamental role of these products in 
presenting foreign membrane-bound antigens and in medi-
ating an interaction between killer and target cells in 
immune reactions. 
Pilarski (79) has demonstrated that cytotoxic T cells are 
presentas pro-killercellsamongthe thymocytes of mice. For 
thymocytes to generate cytotoxic eel Is, hei per T eel Is appear 
to be imperative. These helper Tcells have someof the same 
functional properties as T cells, which help B cells to 
differentiate into antibody-producing plasma cells. The 
helper cells are antigen-specific, theta bearing, radio resist-
ant, and appear predominantly in spleen. In unprimed 
situations they do not display strain specificity. Although the 
mechanism by which helper cells generate killer cells from 
pro-killer thymocytes is not known, two possibilities must 
be entertained: 1) helper cells may acton the precursors ofT 
killer cells probably with the help of an accessory cell; or 2) 
sequential interactions occur in which the helpers act 
indirectly on the killer precursors by first inducing a pro-
helper cell among the thymocyte-derived population to 
expand clonally and to provide help for the killer precursors 
also present in thymus. It is of interest that the helper cells 
that have been irradiated function well in this regard. The 
genes of the / region in mice have been shown to be 
associated with immunoregulatory activities. 
Firm evidence in mice (80) and indirect but convincing 
evidence in humans (81) indicates that help and suppression 
are mediated by distinct subsets of T cells each genetically 
committed to its particular function. In mice, suppressor 
and helper T cells can be identified by Ly alloantigens 
present on their surface membranes. In man, these subsets of 
T lymphocytes have been identified by the presence of 
different receptors for IgM or IgG on their surface (81). 
Immunoregulatory T cells may exist as inactive precursors, 
the pro-helper and pro-suppressor cells (82,83). In human 
leukemic proliferation, malignant deviation of helper, sup-
pressor, and of pro-suppressor T cells has recently been 
described (84). These precursors must interact with another 
setofT cells, the amplifier T cells, before maturing into fully 
functioning helper or suppressor cells. Immunoregulatory 
suppressor funct ions may be ant igen-specif ic or non-
specific. The specificity can be directed to either hapten or 
carrier molecules. In certain systems the effect of suppressor 
cells on target cells is genetically restricted. Suppressor cells 
may regulate the production of all immunoglobulin classes 
(85), a single class of immunoglobulin (86), a single immu-
noglobulin allotype (87), or a single idiotype (88). In some 
systems, suppressor cells affect target cells in a genetically 
restricted fashion; in other systems, no genetic barrier to 
suppressor cell activity is seen. 
In mice it is now possible to define five subregions ofthe I 
segment of the H2 complex: I-A, l-B, I-J, 1-E, and 1-C. I-A 
subregion codes structural information for a soluble helper 
T cell factor (83), and other 1-subregions participate in 
suppressor function. Suppressor Tcells capable of suppress-
ing MLC release a factor that inhibits the reactivity of 
responding cells sharing the same 1-C subregion genotype 
(89). The 1-J subregion appears to encode genetic informa-
tion for surface markers found on suppressor Tcells and also 
for the determinants of soluble suppressor factors derived 
from such cells (90-92). I -J associated suppressor factors are 
antigen specific and mediate profound suppression of both 
specific cellular and antibody-mediated responses. In man 
the genetic control of immunoregulatory functions is largely 
unexplored. However, Engleman and McDevitt (93) have 
reported that HLA-D associated gene products can serve as 
structures permitting T cell subsets to recognize appropriate 
target cells for exertion of suppressor activity. 
Advances in the technology of separating and purifying 
distinct subpopulations of human lymphocytes have per-
mitted the analysisof the linkage of various functionsto T, B, 
and 'third' (unclassified) populations of lymphoid cells in 
man (Table II). Discussion of these functions has recently 
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Properties 
TABLE II 
Functions of Human Lymphocyte Subpopulations 
T Cells B Cells 
'Unclassified' 
Lymphoid 
Cells 
Proliferative Responses 
Antigen 
Allogeneic cells (R) 
Allogeneic cells (S) 
Epstein-Barr Virus 
Cytotoxic Responses 
Cell mediated lympholysis 
Antibody-dependent cytotoxicity 
Natural killer activity 
Mitogen induced cytotoxicity 
Lymphokine Production 
Leukocyte migration inhibition factor 
Macrophage migration inhibition factor 
Blastogenic factor 
Lymphotoxin (a) 
Interferon 
Antibody Synthesis 
Miscellaneous 
Precursors of B Cells 
Precursors of T cells 
Precursors of Granulocytes 
Precursors of E.'-y thro cytes 
+ 
+ 
-FS* 
+ 
+s* 
+s* 
-F 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
-F 
+ 
+ 
-F 
-F 
? 
-F 
-F 
-F 
-F 
+ 
-F 
+ 
? 
-F 
-F 
-F 
-F 
R = Responder 
S = Stimulator 
S* = Subpopulation 
been reviewed in detail (76,94,95). Cells ofal l three popu-
lations respond by proliferation to mitogens (PHA, Con A 
and PWM), but the degree of proliferative response differs. 
While proliferative responses to soluble antigens and al-
logeneic cells in MLC are almost exclusively attributable to 
T lymphocytes, all three populations produce migration 
inhibition factors in response to soluble antigens to which 
the host has been sensitized. Mitogenic factor, interferon 
and lymphotoxin are all produced by each of the major 
subsets of lymphocytes. Only T cells have cytotoxic poten-
tial in cell-mediated lympholysis. Antibody-dependent 
cytotoxicity (ADCC) and spontaneous cytotoxicity (SMLC) 
are mediated by both the 'unclassified' population and by a 
subset o fT cells with IgG (Ty) receptors. 
Tce l l subpopulations identified by the receptors for 
immunoglobulin 
During the sojourn of thymocytes from thymus to the 
peripheral blood and the peripheral tissues, mature T cells 
develop the capacity to express receptors for IgM (T^t), IgG 
(Ty), or IgA (Ta). In addition, a small proportion of T cells in 
the peripheral blood possess receptors for both IgM and IgG, 
'double' receptor, or lack either receptor altogether (T(^). 
J/x and Ty cells have been extensively studied for mor-
phological and functional characteristics (96-99) (Table III). 
They have distinct morphologic characteristics by both light 
and electron microscopy (100). T/u, cells are smaller than Ty 
cells with higher ratio of nucleus to cytoplasm. They also 
have smoother surfaces, a less well developed Golgi appa-
ratus, scanty rough endoplasmic reticulum, and paucity of 
azurophilic granules. By contrast, Ty cells are equipped 
with long microvilli, cytoplasm rich in mitochondria, abun-
dant Golgi, and a well developed, rough endoplasmic 
reticulum. The cytoplasm contains many azurophilic gran-
ules that are PAS negative and Alcian blue negative. The 
RNA content of T/x and Ty cells, as measured by flow 
cytometric analyses, is quite different, as T/x cells contain 
approximately twice the amount of RNA as Ty cells (101). 
Table IV shows the tissue distribution of T cell subsets in 
various lymphoid compartments (17,18). Peripheral blood, 
cord blood and tonsils have comparable proportions ofTp. 
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TABLE III 
Characteristics of Human T Cell Subpopulations 
Characteristics T/LI Cells Ty Cells 
B cell differentiation 
T cell proliferation 
Natural Killer activity 
Antibody-dependent cytotoxicity 
Blastogenic responses to: 
Phytohemagglutinin 
Concanavalin A 
Allogeneic cells 
Mediator Production: 
Migration inhibition factor (LMIF) 
Interfe ron 
Adherence to nylon, wool or plastic 
Locomotor properties 
Histamine receptors 
Thymopoietin 
Corticosteroids 
Irradiation 
' s 
9 
+ 
-F 
Is 
is 
-FS 
-FS 
+ 
-F 
-F 
- S 
T 
-F 
+ 
Sensitivity to: Pronase 
Trypsin 
Neuraminidase 
+ ± 
-F 
+ 
RNA content high low 
Morphology: Nuclear:cytoplasmic ratio high low 
Golgi body rich few 
Rough endoplasmic reticulum abundant scanty 
Cytoplasmic granules -F 
a-nephthyl acetate esterase + 
s = subpopulation 
t =enhancement 
I = inhibition 
and Ty cells, while lymph nodes contain low proportions of 
Ta cells and no Ty cells. The spleen is rich in Ty cells and 
contains low proportions of both T/i, and Ta cells. Thy-
mocytes, in general, lack all Jfx, Ty and Ta phenotypes. 
These figures suggested to us that T cell subsets might have 
different locomotor properties. Using modified Boyden 
chamber assay and bovine casein as a chemoattractant, we 
demonstrated that Tp. cells migrate well into the filters, 
whereas Ty cells either migrated poorly or did not migrate at 
all (102). Further, when Tcell subpopulations are isolated by 
density gradient electrophoresis according to their surface 
charge, J/JL cells were enriched in the high mobility fractions 
and Ty cells in low mobility fractions (103). 
T cell subsets demonstrate differential sensitivities to corti-
costeroid, irradiation, and the inductive influence of thy-
mopoietin (104). Ty cells are radiosensitive, while Tp. cells 
are radioresistant. Ty cells are suppressed in vitro by high 
doses of corticosteroids, but this susceptibility varies among 
different normal individuals, and the concentrations of 
corticosteroids required for the effect cannot be reached 
during therapy in patients. Jp, cells, by contrast, are totally 
resistant to the effect of any reasonable concentration of 
corticosteroids. Thymopoietin pentapeptide increases 
the proportion of Ty cells after incubation with peripheral 
blood T cells in vitro, which suggests that a population of 
precursor Ty cells exists in the peripheral blood that can be 
induced to differentiate to Ty cells. 
Recently, we have analyzed the presence of receptors for 
histamine on T cell subsets. Using histamine-coated 
sepharose bead coluns, we demonstrated that histamine 
receptors are present as a subset of Ty cells but almost 
completely absent from Jp. cells (105). 
Moretta, et al (106) examined the proliferative responses of 
Tju, and Ty cells to PHA and Con A. T/i, and Ty cells 
responded similarly to different concentrations of Con A, 
both in their peak proliferative response and in the kinetics 
of their response. Ty cells, however, did not respond to 
PHA. In contrast, Jp, cells responded with the same peak 
proliferative response as that of unseparated T cells but 
required much higher concentrations of PHA to achieve that 
response. In our own study of proliferative responses in one 
way MLC, both the Jp. and Ty populations responded 
similarly to allogeneic stimulator cells. 
T/i, and Jcf) cells produced leukocyte migration inhibition 
factor (LMIF) in response to PHA or Con A in amounts 
comparable to that produced by unfractionated Tcells (107). 
In contrast, Ty cells either failed to produce LMIF or 
produced less LMIF than that of Jp. cells. 
Moretta, et al (81) have also examined the functional 
properties of T/t and Ty cells in immunoregulatlon of B cell 
differentiation to plasma cells following stimulation with 
pokeweed mitogen (PWM). When Jp, cells were added to B 
cells and cultured in the presence of PWM, differentiation of 
B cells to plasma cells occurred. This reaction indicated that 
T/i, cells may act as helperTcells. In contrast, when Ty cells 
were added to B cells along with PWM, no differentiation to 
plasma cells was observed, suggesting that Ty cells are not 
helper T cells. However, when Ty cells were added to 
culturesofB cells, Jp. cells and PWM, no differentiation of B 
cells to plasma cells was observed. These experiments led 
these investigators to concl ude that T/i, eel Is are hei pers and 
Ty cells are suppressors. Later, it became clear that neither 
of these populations in their entirety are helpers or sup-
pressors. Hayward, et al (108) demonstrated that Jp. cells 
after activation with Con A could suppress differentiation of 
B cells to plasma cells. In another study, such an effect was 
associated with change in surface phenotype [ J p ^ J y ) o ia 
subpopulation of T/i, cells (109). These experiments indicate 
that the Jp. cell population is heterogeneous. Similarly, 
we have demonstrated that it is only a subpopulation of Ty 
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TABLE IV 
Dis t r ibut ion of T Cell Subsets 
Lymphoid Compar tment T M ( % ) M e a n ± S D Ty(%) M e a n ± S D Ta(%) M e a n ± S D 
Peripheral B lood (60) 52.2±10.8 10.4±4.0 (15) 8 .2±4.6 
Cord Blood (24) 46 .0±9,8 22 .2±6.0 (4) 4 .2±2.2 
Tonsils (8) 5 4 . 0 - 1 5 . 0 6 ,4±4,0 (6) 9 .4±3.2 
Bone Marrow (4) 55.0±23.8 8 ,5±4.4 Not Done 
Thymus (8) 2.1 +3.5 3.1 ±3 .2 (2) 0.0 
Spleen (4) 10.4±2.4 48.0±10.2 (4) 2 .4±1.2 
Lymph Nodes (8) 49 .0±6.0 1.6±2.0 (4) 2.23:1.6 
( ) = number of specimens examined 
cells (histamine receptor positive) that mediates suppression 
of either T or B cell responses (105). 
Recently, we have reported (llO)that both T and non-T cells 
can mediate ADCC and natural killer (nk) activity. Among 
the Tcells, both ADCC and nk activity are present in Ty cells 
and absent from Jp. cells. Histamine receptor negative Ty 
cells appear to participate in the killer activity (unpublished 
observations). Clear but indirect evidence both in animals 
and humans suggests that the T cell mediating ADCC 
activity is distinct from that mediating nk. 
The analysis of these two subpopulations, both for their 
numbers and proportions in the peripheral blood and 
lymphoid organs of patients with primary and secondary 
immunodeficiency disorders, demonstrates that an im-
balance among two subsets and maldistribution among 
lymphoid compartments are frequently encountered in pri-
mary and secondary immunodeficiency disorders (111-116). 
Recently, it has been demonstrated that the T cell subsets, 
particularly Ty cells, undergo changes in their surface 
phenotypes and show modulation oftheir functions as well 
(110,117), although these changes occur only when insolu-
ble immune complexes (OxRBC-IgG) are used to isolate 
them from non-Ty cells. It is unclear whether these changes 
occur in vivo in pathologic states associated with circulating 
soluble immune complexes. Ifthis were the case, analysisof 
T cell subsets employing the use of Fc receptors would be 
less useful. However, when we used sera from patients with 
connective tissue diseases who have high levels of circulat-
ing soluble immune complexes, we could not observe a shift 
of phenotype or modulation of their functions, e.g., ADCC 
(unpublished observation). Therefore, the influence of solu-
ble immune complexes in vitro does not correlate with that 
influence in vivo. 
Summary 
From the accumulatingdata, it is evidentthat T lymphocytes 
are at least as heterogenous as B lymphocytes. We can now 
visualize the immune system as having not only two arms 
but also hands and fingers which work together in a 
splendid, highly coordinated fashion. Furthermore, it ap-
pears likely that several more populations of T and B 
lymphocytes wil l be discovered in the future. It wil l be 
important to define the function(s) of each new subpopula-
tion to determine how its functions integrate with the other 
subpopulations before immune systems can be understood 
as a single functional unit. 
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